Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subthalamic nucleus stimulation: improvements in outcome with reprogramming.

Elena Moro1, Yu-Yan W Poon, Andres M Lozano

  • 1Movement Disorders Center and Department of Neurosurgery, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario. elena.moro@uhn.on.ca

Archives of Neurology
|July 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local Field Potential-Based Programming: A Proof-of-Concept Pilot Study.

Neuromodulation : journal of the International Neuromodulation Society·2022
Same author

Toward focused ultrasound neuromodulation in deep brain stimulator implanted patients: Ex-vivo thermal, kinetic and targeting feasibility assessment.

Brain stimulation·2022
Same author

Where Are We with Deep Brain Stimulation? A Review of Scientific Publications and Ongoing Research.

Stereotactic and functional neurosurgery·2022
Same author

Deep brain stimulation for extreme behaviors associated with autism spectrum disorder converges on a common pathway: a systematic review and connectomic analysis.

Journal of neurosurgery·2022
Same author

Commentary: Feasibility of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor in the Setting of Prior Craniotomy.

Operative neurosurgery (Hagerstown, Md.)·2022
Same author

Leukoencephalopathy with brain calcifications and cysts (Labrune syndrome) case report: diagnosis and management of a rare neurological disease.

BMC neurology·2022

Optimizing deep brain stimulation (DBS) for Parkinson disease (PD) by expert reprogramming and medication adjustment can significantly improve motor function and reduce drug dosages in many patients. This hands-on approach enhances long-term outcomes for advanced PD.

Area of Science:

  • Neurology
  • Neurosurgery
  • Movement Disorders

Background:

  • Deep brain stimulation (DBS) is a leading surgical treatment for advanced Parkinson disease (PD).
  • Optimal outcomes require precise programming of stimulation parameters and adjusted medication dosages.
  • Even with stable DBS, further improvements may be possible.

Purpose of the Study:

  • To assess if expert-led reprogramming of subthalamic nucleus DBS and medication adjustments can enhance stable outcomes in PD patients.
  • To evaluate the impact of a neurologist's direct involvement in programming and drug management.

Main Methods:

  • A study of 44 PD patients with long-term subthalamic nucleus DBS (mean 3.5 years).
  • Compared Unified Parkinson's Disease Rating Scale (UPDRS) scores before and after reprogramming by a movement disorder/DBS expert.

Related Experiment Videos

  • Included medication adjustments and up to 14 months follow-up.

    • Main Results:

    • Over 54% of patients showed significant improvement in UPDRS parts II (motor) and III (non-motor) scores (15.0% and 25.9% respectively).
    • Average anti-Parkinsonian drug dosage was reduced by 25.9%.
    • No improvement occurred in 36.4% of patients, and 9.1% worsened.

    Conclusions:

    • Significant improvements in parkinsonian signs are achievable in most patients, even years after DBS implantation.
    • Personalized postoperative care by a neurologist expert in movement disorders and DBS programming is crucial for optimizing patient outcomes.
    • Simultaneous adjustments in stimulation parameters and medication based on clinical response are key to maximizing benefits.